Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases
- PMID: 28415011
- DOI: 10.1016/j.ejmech.2017.04.014
Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases
Abstract
Adenosine induces bronchial hyperresponsiveness and inflammation in asthmatics through activation of A2B adenosine receptor (A2BAdoR). Selective antagonists have been shown to attenuate airway reactivity and improve inflammatory conditions in pre-clinical studies. Hence, the identification of novel, potent and selective A2BAdoR antagonist may be beneficial for the potential treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). Towards this effort, we explored several prop-2-ynylated C8-aryl or heteroaryl substitutions on xanthine chemotype and found that 1-prop-2-ynyl-1H-pyrazol-4-yl moiety was better tolerated at the C8 position. Compound 59, exhibited binding affinity (Ki) of 62 nM but was non-selective for A2BAdoR over other AdoRs. Incorporation of substituted phenyl on the terminal acetylene increased the binding affinity (Ki) significantly to <10 nM. Various substitutions on terminal phenyl group and different alkyl substitutions on N-1 and N-3 were explored to improve the potency, selectivity for A2BAdoR and the solubility. In general, compounds with meta-substituted phenyl provided better selectivity for A2BAdoR compared to that of para-substituted analogs. Substitutions such as basic amines like pyrrolidine, piperidine, piperazine or cycloalkyls with polar group were tried on terminal acetylene, keeping in mind the poor solubility of xanthine analogs in general. However, these substitutions led to a decrease in affinity compared to compound 59. Subsequent SAR optimization resulted in identification of compound 46 with high human A2BAdoR affinity (Ki = 13 nM), selectivity against other AdoR subtypes and with good pharmacokinetic properties. It was found to be a potent functional A2BAdoR antagonist with a Ki of 8 nM in cAMP assay in hA2B-HEK293 cells and an IC50 of 107 nM in IL6 assay in NIH-3T3 cells. Docking study was performed to rationalize the observed affinity data. Structure-activity relationship (SAR) studies also led to identification of compound 36 as a potent A2BAdoR antagonist with Ki of 1.8 nM in cAMP assay and good aqueous solubility of 529 μM at neutral pH. Compound 46 was further tested for in vivo efficacy and found to be efficacious in ovalbumin-induced allergic asthma model in mice.
Keywords: Adenosine; Bioavailability; Heteroaryl; Human liver microsomes; Propargyl; cAMP.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Exploring the structural determinants of novel xanthine derivatives as A2B adenosine receptor antagonists: a computational study.J Biomol Struct Dyn. 2019 Aug;37(13):3467-3481. doi: 10.1080/07391102.2018.1517612. Epub 2018 Nov 17. J Biomol Struct Dyn. 2019. PMID: 30175951
-
A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives.Eur J Med Chem. 2017 Feb 15;127:986-996. doi: 10.1016/j.ejmech.2016.11.007. Epub 2016 Nov 8. Eur J Med Chem. 2017. PMID: 27842891
-
Recent developments in A2B adenosine receptor ligands.Handb Exp Pharmacol. 2009;(193):99-122. doi: 10.1007/978-3-540-89615-9_4. Handb Exp Pharmacol. 2009. PMID: 19639280 Review.
-
Structure-affinity relationships of adenosine A2B receptor ligands.Med Res Rev. 2006 Sep;26(5):667-98. doi: 10.1002/med.20069. Med Res Rev. 2006. PMID: 16847822 Review.
-
Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.J Med Chem. 2006 Jun 15;49(12):3682-92. doi: 10.1021/jm051268+. J Med Chem. 2006. PMID: 16759111
Cited by
-
Pharmacology of Adenosine Receptors: Recent Advancements.Biomolecules. 2023 Sep 14;13(9):1387. doi: 10.3390/biom13091387. Biomolecules. 2023. PMID: 37759787 Free PMC article. Review.
-
Recent Advances in the Synthesis of Xanthines: A Short Review.Scientifica (Cairo). 2022 Nov 8;2022:8239931. doi: 10.1155/2022/8239931. eCollection 2022. Scientifica (Cairo). 2022. PMID: 36398136 Free PMC article. Review.
-
Molecular Simulations and Drug Discovery of Adenosine Receptors.Molecules. 2022 Mar 22;27(7):2054. doi: 10.3390/molecules27072054. Molecules. 2022. PMID: 35408454 Free PMC article. Review.
-
Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma?Front Allergy. 2021 May 31;2:677677. doi: 10.3389/falgy.2021.677677. eCollection 2021. Front Allergy. 2021. PMID: 35386996 Free PMC article. Review.
-
Heterocyclic Compounds: Pharmacology of Pyrazole Analogs From Rational Structural Considerations.Front Pharmacol. 2021 May 10;12:666725. doi: 10.3389/fphar.2021.666725. eCollection 2021. Front Pharmacol. 2021. PMID: 34040529 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical
Miscellaneous